Guardant Health Leads the Way in Blood-Based Single Cancer Screening
As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.
From $27.2 Billion To $42.4 Billion : The Growth Of The Global Railway System Market Forecast, 2021-2031
WILMINGTON, NEW CASTLE, DE, UNITED STATES, February 21, 2025 /EINPresswire / -- According to a new report published by Allied Market Research, titled ...
From $3.8 Billion To $6.5 Billion : Growth Trends In The Automotive Brake Pad Market Forecast, 2021-2031
WILMINGTON, NEW CASTLE, DE, UNITED STATES, February 21, 2025 /EINPresswire / -- According to a new report published by Allied Market Research, titled ...
NBA front office rankings: Celtics, OKC at the top, Mavericks sink after Luka trade, but they're not No. 30
With a wild trade deadline in the rearview mirror, we divided the NBA's 30 front offices into 11 different tiers ...
Neither US States Nor Companies Fully Disclose Corporate Subsidies
Our research suggests that barely 20 states report the governmental assistance they give companies. 80% of firms receiving subsidies worth more than $1 million do not disclose such aid in their 10Ks.